Where is SparingVision headquartered?

SparingVision is located in Paris, île-de-france.

Who invested in SparingVision?

SparingVision has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for SparingVision?

SparingVision closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

sparingvision.com

SparingVision

SparingVision is a France-based genomic medicines company that develops and commercializes synergistic gene therapy for the treatment of inherited retinal diseases.

Business Model:

Revenue: $3M

Employees: 11-50

Geographic Data

Address: 5/7 avenue Percier

City: Paris

State: île-de-france

Zip: 75008

Country: FR

Financial Info

Stage:

corporate round

Raised Last:

$0

Raised Total:

$53M

Social

Twitter

Crunchbase

Metrics

7,929,500Website Global Rank

419Website Monthly Traffic

Twitter Followers

Description

SparingVision is a France-based genomic medicines company that develops and commercializes synergistic gene therapy for the treatment of inherited retinal diseases.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
10/2020	Series A		$52.5M	4BIO Capital Jeito Capital Ysios Capital Bpifrance Foundation Fighting Blindness
10/2021	Corporate Round	1	-	Intellia Therapeutics Intellia Therapeutics
10/2020	Venture Round		$0	4BIO Capital Bpifrance Foundation Fighting Blindness Jeito Capital UPMC Enterprises Ysios Capital 4BIO Capital Bpifrance Foundation Fighting Blindness Jeito Capital UPMC Enterprises Ysios Capital
9/2022	Series B		$75.5M	Jeito Capital UPMC Enterprises 4BIO Capital Bpifrance Retinal Degeneration Fund Ysios Capital
7/2019	Grant		$2.8M
10/2021	Corporate Round		-
7/2017	Series A		$18.1M	Bpifrance Foundation Fighting Blindness
9/2022	Series B		$0	Ysios Capital UPMC Enterprises Retinal Degeneration Fund Jeito Capital Bpifrance 4BIO Capital Ysios Capital UPMC Enterprises Retinal Degeneration Fund Jeito Capital Bpifrance 4BIO Capital
10/2020	Series A	6	$52.7M	Ysios Capital UPMC Enterprises Jeito Capital Foundation Fighting Blindness Bpifrance 4BIO Capital Ysios Capital UPMC Enterprises Jeito Capital Foundation Fighting Blindness Bpifrance 4BIO Capital
10/2021	Corporate Round		-	Intellia Therapeutics, Inc. Intellia Therapeutics, Inc.
10/2021	Corporate Round	1	-	Intellia Therapeutics Intellia Therapeutics
10/2020	Venture Round	6	$52.7M	4BIO Capital Bpifrance Foundation Fighting Blindness Jeito Capital UPMC Enterprises Ysios Capital 4BIO Capital Bpifrance Foundation Fighting Blindness Jeito Capital UPMC Enterprises Ysios Capital

Acquisitions

Announced Date	Name	Price
4/2021	GAMUT Therapeutics

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details